Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.598
-0.012 (-1.90%)
At close: Feb 21, 2025, 4:00 PM
0.609
+0.011 (1.77%)
After-hours: Feb 21, 2025, 5:20 PM EST
Karyopharm Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -76.42 | -143.1 | -165.29 | -124.09 | -196.27 | |
| Depreciation & Amortization | 0.34 | 0.53 | 0.62 | 0.79 | 0.97 | |
| Other Amortization | 6.37 | 0.81 | 0.81 | 0.78 | 8.07 | |
| Asset Writedown & Restructuring Costs | - | - | - | 7.36 | - | |
| Loss (Gain) From Sale of Investments | -2.5 | -4.1 | -0.83 | 1.56 | 1.42 | |
| Stock-Based Compensation | 18.43 | 21.71 | 35.4 | 29.78 | 24.41 | |
| Other Operating Activities | -73.39 | - | -0.28 | -0.11 | -0.19 | |
| Change in Accounts Receivable | -3.8 | 20.12 | -5.08 | -9.62 | -5.02 | |
| Change in Inventory | -1.7 | 1.18 | -0.12 | -1.46 | -2.63 | |
| Change in Accounts Payable | 1.98 | 0.35 | 1.17 | -2.85 | 3.47 | |
| Change in Unearned Revenue | - | - | - | - | -4.24 | |
| Change in Other Net Operating Assets | 3.21 | 9.77 | -15.96 | -9.26 | 9.77 | |
| Operating Cash Flow | -127.49 | -92.72 | -149.55 | -107.12 | -160.23 | |
| Capital Expenditures | -0.14 | - | -0.12 | -0.21 | -0.15 | |
| Sale (Purchase) of Intangibles | - | - | - | -5.5 | - | |
| Investment in Securities | 95.62 | 7.94 | -104.14 | 147.55 | -53.54 | |
| Investing Cash Flow | 95.47 | 7.94 | -104.26 | 141.84 | -53.69 | |
| Long-Term Debt Issued | 83.3 | - | - | - | - | |
| Long-Term Debt Repaid | -40.52 | - | - | - | - | |
| Net Debt Issued (Repaid) | 42.78 | - | - | - | - | |
| Issuance of Common Stock | 1.45 | 1.12 | 193.74 | 13.65 | 172.08 | |
| Other Financing Activities | -2.59 | - | - | 60 | - | |
| Financing Cash Flow | 41.65 | 1.12 | 193.74 | 73.65 | 172.08 | |
| Foreign Exchange Rate Adjustments | -0.01 | -0.03 | -0.49 | -0.05 | 0.27 | |
| Net Cash Flow | 9.62 | -83.69 | -60.56 | 108.32 | -41.57 | |
| Free Cash Flow | -127.63 | -92.72 | -149.67 | -107.33 | -160.38 | |
| Free Cash Flow Margin | -87.88% | -63.49% | -95.29% | -51.15% | -148.38% | |
| Free Cash Flow Per Share | -1.01 | -0.81 | -1.83 | -1.43 | -2.23 | |
| Cash Interest Paid | 38.6 | 21.23 | 34.45 | 15.54 | 11.19 | |
| Levered Free Cash Flow | -77.12 | -39.95 | -101.35 | -58.64 | -88.16 | |
| Unlevered Free Cash Flow | -60.1 | -25.87 | -86.54 | -43.14 | -79.27 | |
| Change in Net Working Capital | 4.07 | -32.85 | 33.57 | 6.58 | -2.91 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.